Boston Scientific Submits Final Modules To FDA For Approval Of Second-Generation Small Vessel And Long Lesion Stents (Medical News Today)
Boston Scientific Corporation (NYSE: BSX) announced that it has submitted to the U.S. Food and Drug Administration (FDA) the final modules of the Company's Pre-Market Approval (PMA) applications for both its TAXUS(R) Liberte(R) Atom(TM) Paclitaxel-Eluting Coronary Stent System and its TAXUS Liberte Long(TM) Paclitaxel-Eluting Coronary Stent System.

FDA Advisory Committee Favors Approval Of DX-88 For Acute Attacks Of Hereditary Angioedema (Medical News Today)
Dyax Corp. (NASDAQ:DYAX) announced that the U.S. Food and Drug Administration's (FDA) Pulmonary-Allergy Advisory Committee voted (6 yes, 5 no, 2 abstentions) in favor of approval of DX-88 (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE). If approved, DX-88 will be the first drug available in the U.S.

FDA Urges Consumers Not To Eat Hundreds Of Products Recalled Because Of Contaminated Peanuts And Peanut Ingredients (Medical News Today)
So far more than 500 cases of foodborne illness caused by Salmonella Typhimurium have been reported. Many of these cases have required hospitalization. The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have confirmed that the sources of this outbreak are peanut products from the Peanut Corporation of America (PCA).